Transforming HCV Management in the Pretransplant and Posttransplant Settings: The Role of New Agents
  • Program Overview
    Transforming HCV Management in the Pretransplant and Posttransplant Settings: The Role of New Agents
    Download slides, review ClinicalThought commentaries, and then participate in the conversation surrounding the use of DAA HCV therapy in liver transplant patients.
  • Featured content
    In this downloadable slideset, Norah Terrault, MD, MPH, leads a review of a series of cases with Jean C. Emond, MD, and Paul Y. Kwo, MD, evaluating the optimal use of available HCV therapies in the pretransplantation and posttransplantation patients.
    Date Posted: 9/16/2014
  • Featured content
    In this downloadable slideset, Jean C. Edmond, MD, offers insight into managing HCV in pretransplant and posttransplant patients.
    Date Posted: 9/15/2014
  • Featured content
    In this downloadable slideset, Paul Y. Kwo, MD, reviews current and forthcoming options for interferon-free treatment of pretransplantation and posttransplantation patients with HCV.
    Date Posted: 9/15/2014
  • 1
  • 2
  • 3
  • 4

Latest Content

3 of 3 Shown
3 of 3 Shown
Show 0 More
Loading...